N. Maillard

发表

Allogeneic stem cell transplantation in therapy-related myelodysplasia after autologous transplantation for lymphoma: a retrospective study of the SFGM-TC.

M. Robin, P. Chevallier, M. Mohty, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

R. Porcher, G. Mufti, C. Craddock, 2017, Bone Marrow Transplantation.

Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS

J. Bourhis, M. Labopin, P. Chevallier, 2016, Cancer medicine.

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia

F. Jardin, J. Tamburini, L. Fornecker, 2018, Haematologica.

Human metapneumovirus pneumonia in patients with hematological malignancies

M. Robin, B. Arnulf, E. Raffoux, 2014, Journal of Clinical Virology.

Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

I. Yakoub-Agha, D. Blaise, J. Bay, 2017, Bone Marrow Transplantation.

Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

J. Soulier, I. Yakoub-Agha, D. Blaise, 2011, Haematologica.

Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

J. Soulier, I. Yakoub-Agha, D. Blaise, 2009 .

N. Kröger, J. Sierra, M. Robin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

I. Yakoub-Agha, C. Leroy, C. Decanter, 2014, Orphanet Journal of Rare Diseases.

Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure

E. Solary, R. Casasnovas, G. Rifle, 1997, Bone Marrow Transplantation.

Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto‐SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM‐TC

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2015, European journal of haematology.

Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party

S. Montoto, N. Kröger, J. Sierra, 2018, Bone Marrow Transplantation.

Longitudinal clonal architecture of acute myeloid leukemia with NPM1 driver insertion, early TET2 mutations and secondary e6a2 BCR-ABL1 rearrangement

X. Leleu, N. Sorel, J. Chomel, 2020, Leukemia & lymphoma.

Relatively favorable outcome after allogeneic stem cell transplantation for BCR‐ABL1‐positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)

J. Esteve, M. Labopin, I. Yakoub-Agha, 2018, American journal of hematology.

Acute myelogenous leukemia with the t(3;12)(q26;p13) translocation: Case report and review of the literature

I. Voutsadakis, N. Maillard, 2003, American journal of hematology.

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

M. Bernard, M. Béné, L. Fornecker, 2017, Blood Cancer Journal.

Long‐term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98‐LEDGF rearrangement

X. Leleu, N. Sorel, J. Chomel, 2019, Cancer medicine.

Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2020, Annals of Hematology.

Impact of Atg-containing Reduced-intensity Conditioning after Single-or Double-unit Allogeneic Cord Blood Transplantation on Behalf of Eurocord and the European Society for Blood and Marrow Transplantation Key Points

H. Einsele, P. Chevallier, I. Yakoub-Agha, 2022 .

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2014, Bone Marrow Transplantation.

Outcome Of Patients With IPSS Intermediate (int) Or High Risk Myelodysplastic Syndrome (MDS) According To Donor Availability: A Multicenter Prospective Non Interventional Study For The SFGM-TC and GFM

R. Porcher, H. Dombret, P. Fenaux, 2013 .

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

R. Porcher, G. Mufti, C. Craddock, 2017, Bone Marrow Transplantation.

Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC

M. Labopin, M. Robin, P. Chevallier, 2022, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

A. Baruchel, P. Chevallier, I. Yakoub-Agha, 2022, Journal of Cancer Research and Clinical Oncology.

Low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study

S. Ragot, X. Leleu, A. Herbelin, 2020, Cancer.

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party

N. Kröger, S. Iacobelli, E. Tholouli, 2017, Haematologica.

Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study.

C. Elie, A. Buzyn, F. Fakhouri, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Salvage haploidentical or cord‐blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM‐TC

M. Robin, P. Chevallier, G. Guillerm, 2022, European journal of haematology.

Treatment of Relapse After Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome: A Large-Scale Study On Behalf of the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

M. Robin, I. Yakoub-Agha, D. Blaise, 2012 .

Transient Pulmonary Infiltrates during Treatment with Anti-Thymocyte Globulin

P. Foucher, D. Caillot, P. Camus, 1999, Respiration.

Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM

R. Porcher, H. Dombret, M. Robin, 2015, Leukemia.

Younger donor’s age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

J. Bourhis, I. Yakoub-Agha, D. Blaise, 2012, Haematologica.

Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.

S. Chevret, P. Chevallier, I. Yakoub-Agha, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapamycin for Refractory Acute Graft-Versus-Host Disease

O. Hermine, F. Suarez, A. Buzyn, 2009, Transplantation.

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on gonadal failure and fertility].

I. Yakoub-Agha, F. Bauters, C. Decanter, 2013, Pathologie-biologie.

[Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on dyslipidemia and thyroid disorders].

I. Yakoub-Agha, F. Bauters, C. Decanter, 2013, Pathologie-biologie.

[Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on adrenal insufficiency and osteoporosis].

I. Yakoub-Agha, F. Bauters, C. Decanter, 2013, Pathologie-biologie.

Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.

M. Robin, I. Yakoub-Agha, D. Blaise, 2013, Experimental hematology.

Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Mal

J. Bourhis, C. Craddock, M. Labopin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double Cord Blood Transplantation: Incidence, Organ Involvement and Risk Factors of Acute Graft Versus Host Disease. a Retrospective Analysis on Behalf of Eurocord, ALWP and Cqwp-EBMT

J. Bourhis, C. Craddock, M. Labopin, 2014 .

Effect of Azithromycin on Airflow Decline–Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial

S. Chevret, M. Bernard, P. Chevallier, 2017, JAMA.

Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.

S. Chevret, M. Robin, E. Bergot, 2015, American journal of respiratory and critical care medicine.

Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.

B. Knebelmann, C. Combe, F. Glowacki, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

G. Socié, N. Milpied, P. Bordigoni, 2007, Haematologica.

Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers

P. Chevallier, I. Yakoub-Agha, M. Mohty, 2017, Haematologica.

Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia

B. Drénou, T. Leblanc, L. Adès, 2017, Haematologica.

Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire

P. Chevallier, M. Mohty, J. Cassuto, 2016, Transplantation.

Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study

P. Chevallier, M. Béné, R. Gressin, 2022, Acta oncologica.

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2018, American journal of hematology.

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC

H. Tilly, P. Chevallier, D. Blaise, 2016, Bone Marrow Transplantation.

Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

J. Bourhis, P. Chevallier, D. Blaise, 2016, Bone Marrow Transplantation.

Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT

M. Mohty, P. Rohrlich, E. Deconinck, 2016, Haematologica.

High‐dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose

R. Porcher, O. Hermine, A. Buzyn, 2002, Transfusion.

A. Baruchel, P. Chevallier, I. Yakoub-Agha, 2021, Journal of Cancer Research and Clinical Oncology.

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

F. Jardin, T. Petrella, E. Macintyre, 2019, Blood advances.

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

M. Robin, D. Blaise, G. Guillerm, 2023, Bone Marrow Transplantation.

Outcomes After Unrelated Cord Blood Transplantation For Adults With Primary Or Secondary Myelofibrosis: A Retrospective Study On Behalf Of Eurocord and Chronic Malignancy Working Party-EBMT

N. Kröger, J. Sierra, M. Robin, 2013 .

HLA‐DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation

R. Porcher, P. van Endert, P. Chevallier, 2018, American journal of hematology.

Medication non‐adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

J. Bourhis, I. Yakoub-Agha, J. Bay, 2020, Fundamental & clinical pharmacology.

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

R. Houot, S. Chevret, L. Michel, 2023, The Lancet.

Pulmonary alveolar proteinosis after allogeneic hematopoietic stem cell transplantation in adults: a French SFGM-TC survey.

M. Robin, V. Meignin, J. Bernaudin, 2021, Chest.

Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia

H. Dombret, T. Cluzeau, C. Récher, 2021, Leukemia & lymphoma.

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

R. Houot, S. Chevret, L. Michel, 2023, The Lancet.

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study

R. Bouabdallah, N. Brousse, C. Sebban, 2002, Leukemia.

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Bourhis, I. Yakoub-Agha, D. Blaise, 2012, Haematologica.

IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation

E. Forcade, M. Couturier, A. Berceanu, 2024, HemaSphere.

Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation.

H. Einsele, P. Chevallier, I. Yakoub-Agha, 2015, Blood.

J. Bourhis, C. Craddock, M. Labopin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2015, European journal of haematology.

Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, A. Nagler, M. Mohty, 2023, Bone Marrow Transplantation.

N. Kröger, J. Sierra, M. Robin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.